Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
NMR Biomed ; 30(8)2017 Aug.
Article in English | MEDLINE | ID: mdl-28430379

ABSTRACT

Although oxygen consumption is a key factor in metabolic phenotyping, its assessment in tumors remains critical, as current technologies generally display poor specificity. The objectives of this study were to explore the feasibility of direct 17 O nuclear magnetic resonance (NMR) spectroscopy to assess oxygen metabolism in tumors and its modulations. To investigate the impact of hypometabolism induction in the murine fibrosarcoma FSAII tumor model, we monitored the oxygen consumption of normothermic (37°C) and hypothermic (32°C) tumor-bearing mice. Hypothermic animals showed an increase in tumor pO2 (measured by electron paramagnetic resonance oximetry) contrary to normothermic animals. This was related to a decrease in oxygen consumption rate (assessed using 17 O magnetic resonance spectroscopy (MRS) after the inhalation of 17 O2 -enriched gas). This study highlights the ability of direct 17 O MRS to measure oxygen metabolism in tumors and modulations of tumor oxygen consumption rate.


Subject(s)
Hypothermia, Induced , Magnetic Resonance Spectroscopy , Neoplasms/metabolism , Oxygen Consumption , Oxygen Isotopes/metabolism , Animals , Male , Mice , Water
2.
Neoplasia ; 18(12): 742-752, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27889643

ABSTRACT

The study of alterations of tumor metabolism should allow the identification of new targets for innovative anticancer strategies. Metabolic alterations are generally established in vitro, and conclusions are often extrapolated to the in vivo situation without further tumor metabolic phenotyping. To highlight the key role of microenvironment on tumor metabolism, we studied the response of glycolytic and oxidative tumor models to metabolic modulations in vitro and in vivo. MDA-MB-231 and SiHa tumor models, characterized in vitro as glycolytic and oxidative, respectively, were studied. Theoretically, when passing from a hypoxic state to an oxygenated state, a Warburg phenotype should conserve a glycolytic metabolism, whereas an oxidative phenotype should switch from glycolytic to oxidative metabolism (Pasteur effect). This challenge was applied in vitro and in vivo to evaluate the impact of different oxic conditions on glucose metabolism. 18F-fluorodeoxyglucose uptake, lactate production, tumor oxygenation, and metabolic fluxes were monitored in vivo using positron emission tomography, microdialysis, electron paramagnetic resonance imaging, and 13C-hyperpolarizated magnetic resonance spectroscopy, respectively. In vitro, MDA-MB-231 cells were glycolytic under both hypoxic and oxygenated conditions, whereas SiHa cells underwent a metabolic shift after reoxygenation. On the contrary, in vivo, the increase in tumor oxygenation (induced by carbogen challenge) led to a similar metabolic shift in glucose metabolism in both tumor models. The major discordance in metabolic patterns observed in vitro and in vivo highlights that any extrapolation of in vitro metabolic profiling to the in vivo situation should be taken cautiously and that metabolic phenotyping using molecular imaging is mandatory in vivo.


Subject(s)
Metabolome , Multimodal Imaging , Neoplasms/diagnostic imaging , Neoplasms/metabolism , Animals , Cell Line, Tumor , Disease Models, Animal , Electron Spin Resonance Spectroscopy , Glucose/metabolism , Glycolysis , Heterografts , Humans , Magnetic Resonance Spectroscopy , Oxidation-Reduction , Oxygen/metabolism , Phenotype , Positron Emission Tomography Computed Tomography
3.
Adv Exp Med Biol ; 876: 209-214, 2016.
Article in English | MEDLINE | ID: mdl-26782214

ABSTRACT

The aim of the study was to assess the link between the metabolic profile and the proliferation capacity of a range of human and murine cancer cell lines. First, the combination of mitochondrial respiration and glycolytic efficiency measurements allowed the determination of different metabolic profiles among the cell lines, ranging from a mostly oxidative to a mostly glycolytic phenotype. Second, the study revealed that cell proliferation, evaluated by DNA synthesis measurements, was statistically correlated to glycolytic efficiency. This indicated that glycolysis is the key energetic pathway linked to cell proliferation rate. Third, to validate this hypothesis and exclude non-metabolic factors, mitochondria-depleted were compared to wild-type cancer cells, and the data showed that enhanced glycolysis observed in mitochondria-depleted cells is also associated with an increase in proliferation capacity.


Subject(s)
Energy Metabolism , Neoplasms/metabolism , Animals , Cell Line, Tumor , Cell Proliferation , Glycolysis , Humans , Mice , Mitochondria/metabolism , Neoplasms/pathology , Oxygen Consumption
4.
Oncotarget ; 7(49): 81741-81749, 2016 Dec 06.
Article in English | MEDLINE | ID: mdl-28082726

ABSTRACT

Reverting glycolytic metabolism is an attractive strategy for cancer therapy as upregulated glycolysis is a hallmark in various cancers. Dichloroacetate (DCA), long used to treat lactic acidosis in various pathologies, has emerged as a promising anti-cancer drug. By inhibiting the pyruvate dehydrogenase kinase, DCA reactivates the mitochondrial function and decreases the glycolytic flux in tumor cells resulting in cell cycle arrest and apoptosis. We recently documented that DCA was able to induce a metabolic switch preferentially in glycolytic cancer cells, leading to a more oxidative phenotype and decreasing proliferation, while oxidative cells remained less sensitive to DCA treatment. To evaluate the relevance of this observation in vivo, the aim of the present study was to characterize the effect of DCA in glycolytic MDA-MB-231 tumors and in oxidative SiHa tumors using advanced pharmacodynamic metabolic biomarkers. Oxygen consumption, studied by 17O magnetic resonance spectroscopy, glucose uptake, evaluated by 18F-FDG PET and pyruvate transformation into lactate, measured using hyperpolarized 13C-magnetic resonance spectroscopy, were monitored before and 24 hours after DCA treatment in tumor bearing mice. In both tumor models, no clear metabolic shift was observed. Surprisingly, all these imaging parameters concur to the conclusion that both glycolytic tumors and oxidative tumors presented a similar response to DCA. These results highlight a major discordance in metabolic cancer cell bioenergetics between in vitro and in vivo setups, indicating critical role of the local microenvironment in tumor metabolic behaviors.


Subject(s)
Antineoplastic Agents/pharmacology , Breast Neoplasms/drug therapy , Carbon-13 Magnetic Resonance Spectroscopy , Carcinoma, Squamous Cell/drug therapy , Dichloroacetic Acid/pharmacology , Energy Metabolism/drug effects , Magnetic Resonance Imaging , Positron Emission Tomography Computed Tomography , Uterine Cervical Neoplasms/drug therapy , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/metabolism , Carcinoma, Squamous Cell/diagnostic imaging , Carcinoma, Squamous Cell/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Enzyme Inhibitors/pharmacology , Female , Glycolysis/drug effects , Humans , Lactic Acid/metabolism , Oxidation-Reduction , Oxygen Consumption/drug effects , Predictive Value of Tests , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/metabolism , Pyruvate Dehydrogenase Acetyl-Transferring Kinase , Pyruvic Acid/metabolism , Time Factors , Uterine Cervical Neoplasms/diagnostic imaging , Uterine Cervical Neoplasms/metabolism , Xenograft Model Antitumor Assays
5.
Oncotarget ; 7(3): 2910-20, 2016 Jan 19.
Article in English | MEDLINE | ID: mdl-26543237

ABSTRACT

Glucose fermentation through glycolysis even in the presence of oxygen (Warburg effect) is a common feature of cancer cells increasingly considered as an enticing target in clinical development. This study aimed to analyze the link between metabolism, energy stores and proliferation rates in cancer cells. We found that cell proliferation, evaluated by DNA synthesis quantification, is correlated to glycolytic efficiency in six cancer cell lines as well as in isogenic cancer cell lines. To further investigate the link between glycolysis and proliferation, a pharmacological inhibitor of the pentose phosphate pathway (PPP) was used. We demonstrated that reduction of PPP activity decreases cancer cells proliferation, with a profound effect in Warburg-phenotype cancer cells. The crucial role of the PPP in sustaining cancer cells proliferation was confirmed using siRNAs against glucose-6-phosphate dehydrogenase, the first and rate-limiting enzyme of the PPP. In addition, we found that dichloroacetate (DCA), a new clinically tested compound, induced a switch of glycolytic cancer cells to a more oxidative phenotype and decreased proliferation. By demonstrating that DCA decreased the activity of the PPP, we provide a new mechanism by which DCA controls cancer cells proliferation.


Subject(s)
Cell Proliferation/drug effects , Dichloroacetic Acid/pharmacology , Glycolysis/physiology , Neoplasms/metabolism , Pentose Phosphate Pathway/drug effects , Pentose Phosphate Pathway/physiology , Adenosine Triphosphate/metabolism , Animals , Cell Line, Tumor , Glucose/metabolism , Glucosephosphate Dehydrogenase/genetics , Humans , Mice , Mitochondria/metabolism , Oxidation-Reduction , Oxygen Consumption/physiology , RNA Interference , RNA, Small Interfering/genetics
6.
Mol Cancer Ther ; 15(1): 154-61, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26682572

ABSTRACT

Hydrogen sulfide (H2S) is the last gaseous transmitter identified in mammals, and previous studies have reported disparate conclusions regarding the implication of H2S in cancer progression. In the present study, we hypothesized that sodium hydrosulfide (NaHS), a fast H2S-releasing donor, might interfere with the mitochondrial respiratory chain of tumor cells, increase tumor oxygenation, and potentiate the response to irradiation. Using electron paramagnetic resonance (EPR) oximetry, we found a rapid increase in tumor pO2 after NaHS administration (0.1 mmol/kg) in two human tumor models (breast MDA-MB-231 and cervix SiHa), an effect that was due to a decreased oxygen consumption and an increased tumor perfusion. Tumors irradiated 15 minutes after a single NaHS administration were more sensitive to irradiation compared with those that received irradiation alone (increase in growth delay by 50%). This radiosensitization was due to the oxygen effect, as the increased growth delay was abolished when temporarily clamped tumors were irradiated. In contrast, daily NaHS injection (0.1 mmol/kg/day for 14 days) did not provide any effect on tumor growth in vivo. To understand these paradoxical data, we analyzed the impact of external factors on the cellular response to NaHS. We found that extracellular pH had a dramatic effect on the cell response to NaHS, as the proliferation rate (measured in vitro by BrdU incorporation) was increased at pH = 7.4, but decreased at pH = 6.5. Overall, our study highlights the complex role of environmental components in the response of cancer cells to H2S and suggests a new approach for the use of H2S donors in combination with radiotherapy.


Subject(s)
Hydrogen Sulfide/pharmacology , Neoplasms/metabolism , Radiation-Sensitizing Agents/pharmacology , Sulfides/pharmacology , Adenosine Triphosphate/metabolism , Animals , Cell Line, Tumor , Cell Proliferation/drug effects , Disease Models, Animal , Female , Glucose/metabolism , Humans , Hydrogen Sulfide/administration & dosage , Hypoxia/drug therapy , Hypoxia/metabolism , Mice , Neoplasms/pathology , Neoplasms/radiotherapy , Oxygen Consumption/drug effects , Radiation-Sensitizing Agents/administration & dosage , Sulfides/administration & dosage , Tumor Burden/drug effects , Xenograft Model Antitumor Assays
7.
NMR Biomed ; 28(3): 367-75, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25611487

ABSTRACT

Cell tracking could be useful to elucidate fundamental processes of cancer biology such as metastasis. The aim of this study was to visualize, using MRI, and to quantify, using electron paramagnetic resonance (EPR), the entrapment of murine breast cancer cells labeled with superparamagnetic iron oxide particles (SPIOs) in the mouse brain after intracardiac injection. For this purpose, luciferase-expressing murine 4 T1-luc breast cancer cells were labeled with fluorescent Molday ION Rhodamine B SPIOs. Following intracardiac injection, SPIO-labeled 4 T1-luc cells were imaged using multiple gradient-echo sequences. Ex vivo iron oxide quantification in the mouse brain was performed using EPR (9 GHz). The long-term fate of 4 T1-luc cells after injection was characterized using bioluminescence imaging (BLI), brain MRI and immunofluorescence. We observed hypointense spots due to SPIO-labeled cells in the mouse brain 4 h after injection on T2 *-weighted images. Histology studies showed that SPIO-labeled cancer cells were localized within blood vessels shortly after delivery. Ex vivo quantification of SPIOs showed that less than 1% of the injected cells were taken up by the mouse brain after injection. MRI experiments did not reveal the development of macrometastases in the mouse brain several days after injection, but immunofluorescence studies demonstrated that these cells found in the brain established micrometastases. Concerning the metastatic patterns of 4 T1-luc cells, an EPR biodistribution study demonstrated that SPIO-labeled 4 T1-luc cells were also entrapped in the lungs of mice after intracardiac injection. BLI performed 6 days after injection of 4 T1-luc cells showed that this cell line formed macrometastases in the lungs and in the bones. Conclusively, EPR and MRI were found to be complementary for cell tracking applications. MRI cell tracking at 11.7 T allowed sensitive detection of isolated SPIO-labeled cells in the mouse brain, whereas EPR allowed the assessment of the number of SPIO-labeled cells in organs shortly after injection.


Subject(s)
Brain/pathology , Cell Tracking/methods , Electron Spin Resonance Spectroscopy/methods , Magnetic Resonance Imaging/methods , Mammary Neoplasms, Animal/pathology , Animals , Cell Line, Tumor , Dextrans/metabolism , Female , Injections , Luminescent Measurements , Lung/metabolism , Magnetite Nanoparticles , Mice, Inbred BALB C , Myocardium/metabolism , Organ Specificity , Rhodamines/metabolism , Staining and Labeling , Time Factors , Tissue Distribution
8.
Contrast Media Mol Imaging ; 9(2): 143-53, 2014.
Article in English | MEDLINE | ID: mdl-24523059

ABSTRACT

MRI cell tracking is a promising technique for tracking various cell types in living animals. Usually, cells are incubated with iron oxides so that the particles are taken up before the cells are injected in vivo. In the present study, we aimed to monitor migration of luciferase-expressing mouse renal cancer cells (RENCA-luc) after intrarenal or intrasplenic injection. These cells were labelled using Molday Ion Rhodamine B (MIRB) fluorescent superparamagnetic iron oxide particles. Their fate after injection was first assessed using ex vivo X-band electron paramagnetic resonance (EPR) spectroscopy. This biodistribution study showed that RENCA-luc cells quickly colonized the lungs and the liver after intrarenal and intrasplenic injection, respectively. Bioluminescence imaging (BLI) studies confirmed that this cell line preferentially metastasized to these organs. Early tracking of labelled RENCA-luc cells in the liver using high-field MRI (11.7 T) was not feasible because of a lack of sensitivity. MRI of MIRB-labelled RENCA-luc cells after injection in the left kidney was then performed. T2 - and T2 *-weighted images showed that the labelled cells induced hypointense signals at the injection site. Nevertheless, the hypointense regions tended to disappear after several days, mainly owing to dilution of the MIRB iron oxides with cell proliferation. In conclusion, EPR is well adapted to ex vivo analysis of tissues after cell tracking experiments and allows short-term monitoring of metastasizing cells. MRI is a suitable tool for checking labelled cells at their injection site, but dilution of the iron oxides owing to cell division remains a major limitation. BLI remains the most suitable technique for long-term monitoring of metastatic cells.


Subject(s)
Cell Tracking/methods , Electron Spin Resonance Spectroscopy/methods , Kidney Neoplasms/diagnosis , Magnetic Resonance Imaging/methods , Animals , Cell Proliferation , Contrast Media , Ferric Compounds , Humans , Kidney Neoplasms/pathology , Luminescent Measurements , Mice , Neoplasm Metastasis , Rhodamines
9.
Semin Radiat Oncol ; 23(4): 262-72, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24012340

ABSTRACT

Most solid tumors are characterized by unstable perfusion patterns, creating regions of hypoxia that are detrimental to radiotherapy treatment response. Because postsurgical radiotherapy, alone or in combination with other interventions, is a first-line treatment for many malignancies, strategies aimed at homogeneously increasing tumor pO2 have been the focus of intense research over the past decades. Among other approaches of demonstrable clinical and preclinical utility, this review focuses on those directly targeting oxygen consumption to redirect oxygen from a metabolic fate to the stabilization of radiation-induced DNA damage, more particularly drugs targeting glucose and lactate metabolism, nitric oxide donors or inducers, and mitogen-activated protein kinase pathway inhibitors. Their utility as adjuvant treatments with radiotherapy has been proven preclinically, which should foster further their clinical development and evaluation.


Subject(s)
Cell Hypoxia/radiation effects , Neoplasms/metabolism , Neoplasms/radiotherapy , Oxygen/metabolism , Radiation-Sensitizing Agents/pharmacology , Animals , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Glucose/metabolism , Glycolysis/radiation effects , Humans , Lactates/metabolism , Nitric Oxide/metabolism , Nitric Oxide/pharmacology , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase/pharmacology
10.
PLoS One ; 8(1): e53324, 2013.
Article in English | MEDLINE | ID: mdl-23382841

ABSTRACT

Cell detachment is a procedure routinely performed in cell culture and a necessary step in many biochemical assays including the determination of oxygen consumption rates (OCR) in vitro. In vivo, cell detachment has been shown to exert profound metabolic influences notably in cancer but also in other pathologies, such as retinal detachment for example. In the present study, we developed and validated a new technique combining electron paramagnetic resonance (EPR) oximetry and the use of cytodex 1 and collagen-coated cytodex 3 dextran microbeads, which allowed the unprecedented comparison of the OCR of adherent and detached cells with high sensitivity. Hence, we demonstrated that both B16F10 melanoma cells and human umbilical vein endothelial cells (HUVEC) experience strong OCR decrease upon trypsin or collagenase treatments. The reduction of cell oxygen consumption was more pronounced with a trypsin compared to a collagenase treatment. Cells remaining in suspension also encounter a marked intracellular ATP depletion and an increase in the lactate production/glucose uptake ratio. These findings highlight the important influence exerted by cell adhesion/detachment on cell respiration, which can be probed with the unprecedented experimental assay that was developed and validated in this study.


Subject(s)
Cell Respiration/physiology , Melanoma, Experimental/physiopathology , Oxygen Consumption , Respiratory Rate , Cell Adhesion/physiology , Cell Line, Tumor , Cells, Cultured , Dextrans/chemistry , Electron Spin Resonance Spectroscopy , Endothelial Cells/physiology , Human Umbilical Vein Endothelial Cells , Humans , Oximetry
11.
PLoS One ; 7(7): e40772, 2012.
Article in English | MEDLINE | ID: mdl-22808261

ABSTRACT

BACKGROUND: Paclitaxel (PTX) is a potent anti-cancer chemotherapeutic agent and is widely used in the treatments of solid tumors, particularly of the breast and ovaries. An effective and safe micellar formulation of PTX was used to administer higher doses of PTX than Taxol® (the current commercialized drug). We hypothesize that PTX-loaded micelles (M-PTX) may enhance tumor radiosensitivity by increasing the tumor oxygenation (pO(2)). Our goals were (i) to evaluate the contribution of the "oxygen effect" to the radiosensitizing effect of PTX; (ii) to demonstrate the therapeutic relevance of the combination of M-PTX and irradiation and (iii) to investigate the underlying mechanisms of the observed oxygen effect. METHODOLOGY AND PRINCIPAL FINDINGS: We used (PEG-p-(CL-co-TMC)) polymeric micelles to solubilize PTX. pO(2) was measured on TLT tumor-bearing mice treated with M-PTX (80 mg/kg) using electron paramagnetic resonance (EPR) oximetry. The regrowth delay following 10 Gy irradiation 24 h after M-PTX treatment was measured. The tumor perfusion was assessed by the patent blue staining. The oxygen consumption rate and the apoptosis were evaluated by EPR oximetry and the TUNEL assay, respectively. EPR oximetry experiments showed that M-PTX dramatically increases the pO(2) 24 h post treatment. Regrowth delay assays demonstrated a synergy between M-PTX and irradiation. M-PTX increased the tumor blood flow while cells treated with M-PTX consumed less oxygen and presented more apoptosis. CONCLUSIONS: M-PTX improved the tumor oxygenation which leads to synergy between this treatment and irradiation. This increased pO(2) can be explained both by an increased blood flow and an inhibition of O(2) consumption.


Subject(s)
Electron Spin Resonance Spectroscopy/methods , Oxygen/pharmacology , Paclitaxel/pharmacology , Radiation-Sensitizing Agents/pharmacology , Animals , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , In Situ Nick-End Labeling , Male , Mice , Micelles , Models, Biological , Neoplasms/drug therapy , Neoplasms/metabolism , Neoplasms/pathology , Oxygen Consumption/drug effects , Paclitaxel/administration & dosage , Paclitaxel/therapeutic use , Partial Pressure , Perfusion , Radiation-Sensitizing Agents/therapeutic use , Staining and Labeling
SELECTION OF CITATIONS
SEARCH DETAIL
...